Stocks and Investing Stocks and Investing
Thu, August 10, 2023

David Amsellem Maintained (AVDL) at Buy with Increased Target to $18 on, Aug 10th, 2023


Published on 2024-10-28 05:46:13 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $13 to $18 on, Aug 10th, 2023.

David has made no other calls on AVDL in the last 4 months.



There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $25 on, Friday, June 30th, 2023
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
  • Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023

Contributing Sources